Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell Therapies
January 05, 2015 at 09:07 AM EST
Amgen (NASDAQ: AMGN) and Kite Pharma (NASDAQ: KITE) announced today that the two companies have entered into a strategic research ...